Patents by Inventor Monique Cervilla

Monique Cervilla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6013284
    Abstract: A synthetic particulate vector comprising a non-liquid hydrophilic nucleus and an outer layer at least partially consisting of amphiphilic compounds, which is combined with the nucleus by hydrophobic interactions and/or ionic bonds. A process for preparing a particulate vector by encapsulating an ionizable active principle, vectors obtained according to such a process, and pharmaceutical, cosmeticological and food compositions comprising such vectors are also disclosed.
    Type: Grant
    Filed: May 1, 1996
    Date of Patent: January 11, 2000
    Assignee: Biovector Therapeutics S.A.
    Inventors: Daniel Samain, Pascal Delrieu, Joelle Gibilaro, Roselyne Dirson, Monique Cervilla, Ignacio De Miguel, Li Ding, Frederique Nguyen, Nadine Soulet, Corinne Soler
  • Patent number: 5968794
    Abstract: A biodegradable particulate vector for transporting biologically active molecules is prepared containing a nucleus formed of a cross-linked polysaccharide or oligosaccharide matrix having grafted ionic ligands, a layer of fatty acid compounds covalently bonded to the nucleus and a layer of phospholipids hydrophobically bonded to the layer of fatty acid compounds. Dextran, cellulose or starch may be cross-linked with epichlorohydrin to form a cross-linked polysaccharide matrix. Ionic ligands may be grafted using an acidic compound such as succinic acid, phosphoric acid or phosphorous oxychloride, or a basic compound such as choline, hydroxycholine, 2-(dimethylamino)ethanol or 2-(dimethylamino) ethylamine fastened onto the grafted acidic compound. Phosphoric acid or phosphorous oxychloride in one step provide both cross-linking and ionic ligands. Co-cross-linking can be obtained using a protein such as keratin, collagen or elastase.
    Type: Grant
    Filed: January 23, 1998
    Date of Patent: October 19, 1999
    Assignee: Biovector Therapeutics S.A.
    Inventors: Daniel Samain, Ignacio De Miguel, Jaouad Meniali, Karim Ioualalen, Li Ding, Monique Cervilla, Valerie Rieumajou, Pascal Delrieu, Laurent Imbertie
  • Patent number: 5736371
    Abstract: A biodegradable particulate vector for transporting biologically active molecules is prepared containing a nucleus for containing a biologically active molecule, a first layer of fatty acid compounds covalently bonded to the nucleus and a second layer of phospholipids hydrophobically bonded to the first layer. The nucleus is between 10 nm and 10 .mu.m in size and is formed of a cross-linked polysaccharide or oligosaccharide matrix onto which ionic ligands are uniformly grafted. The cross-linked polysaccharide may be dextran, cellulose or starch cross-linked with epichlorohydrin. The ligand may be an acidic compound selected from succinic acid, phosphoric acid, citric acid, glycine, alanine, glutamic acid and aspartic acid, or a basic compound such as choline, hydroxycholine, 2-(dimethylamino)ethanol or 2-(dimethylamino)ethylamine fastened onto the matrix via the acidic compound. The polysaccharide or oligosaccharide may be co-cross-linked with a protein such as keratin/collagen or elastase.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: April 7, 1998
    Assignee: A et S Biovecteurs
    Inventors: Daniel Samain, Ignacio De Miguel, Jaouad Meniali, Karim Ioualalen, Li Ding, Monique Cervilla, Valerie Rieumajou, Pascal Delrieu, Laurent Imbertie